home / stock / veru / veru quote
Last: | $0.9147 |
---|---|
Change Percent: | -4.08% |
Open: | $0.99 |
Close: | $0.9536 |
High: | $0.99 |
Low: | $0.8876 |
Volume: | 1,119,497 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.9147 | $0.99 | $0.9536 | $0.99 | $0.8876 | 1,119,497 | 07-03-2024 |
$0.9536 | $0.87 | $0.9536 | $0.9797 | $0.87 | 4,521,755 | 07-02-2024 |
$0.8787 | $0.84 | $0.8787 | $0.898 | $0.8153 | 1,522,118 | 07-01-2024 |
$0.8413 | $0.8 | $0.8413 | $0.88 | $0.7626 | 15,881,656 | 06-28-2024 |
$0.8 | $0.83 | $0.8 | $0.86 | $0.7822 | 1,324,748 | 06-27-2024 |
$0.7989 | $0.807 | $0.7989 | $0.8476 | $0.77 | 1,127,254 | 06-26-2024 |
$0.7946 | $0.878 | $0.7946 | $0.8796 | $0.7907 | 834,818 | 06-25-2024 |
$0.8514 | $0.78 | $0.8514 | $0.8649 | $0.78 | 1,707,650 | 06-24-2024 |
$0.7808 | $0.78 | $0.7808 | $0.791386 | $0.75 | 674,633 | 06-21-2024 |
$0.78 | $0.8122 | $0.78 | $0.8432 | $0.745 | 1,836,262 | 06-20-2024 |
$0.8031 | $0.8361 | $0.8031 | $0.85 | $0.7903 | 1,015,698 | 06-19-2024 |
$0.8031 | $0.8361 | $0.8031 | $0.85 | $0.7903 | 1,015,698 | 06-18-2024 |
$0.8319 | $0.8133 | $0.8319 | $0.8417 | $0.78 | 740,946 | 06-17-2024 |
$0.8133 | $0.8382 | $0.8133 | $0.8468 | $0.7953 | 1,194,427 | 06-14-2024 |
$0.8385 | $0.9 | $0.8385 | $0.923381 | $0.8311 | 1,285,000 | 06-13-2024 |
$0.8888 | $0.94 | $0.8888 | $0.97 | $0.87 | 1,620,963 | 06-12-2024 |
$0.9293 | $0.97 | $0.9293 | $0.97 | $0.9001 | 593,483 | 06-11-2024 |
$0.9017 | $0.9 | $0.9017 | $0.9699 | $0.8845 | 3,544,268 | 06-10-2024 |
$0.9182 | $0.9141 | $0.9182 | $0.9182 | $0.8803 | 1,053,843 | 06-07-2024 |
$0.9214 | $0.9899 | $0.9214 | $0.9899 | $0.88 | 1,933,167 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...
MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...